Charleston, SC -- (SBWIRE) -- 09/30/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Westinghouse Solar Inc (OTCMKTS:WEST), Globalstar, Inc. (OTCMKTS:GSAT), Biozone Pharmaceuticals Inc (OTCBB:BZNE), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT)
Westinghouse Solar Inc (OTCMKTS:WEST)’s shares traded down -16.00% during current trading session, hitting $0.0420 recently.
The share price of WEST is currently trading with-in the range of $0.04 to $0.05. The company has a market capitalization of $3.42 million whereas its total outstanding shares are 81.42 million. Company’s beta value stands at 2.13 points. WEST’s current trading volume is 3.90 million while its average volume is 1.41 million shares. Andalay Solar, Inc. designs, manufactures, markets, and sells solar power systems and solar panels with integrated micro inverters in the United States and Canada.
Why Should Investors Buy WEST After the Recent Fall? Just Go Here and Find Out
Globalstar, Inc. (OTCMKTS:GSAT)’s shares traded down -2.88% during current trading session, hitting $1.01 recently. The share price of GSAT is currently trading with-in the range of $1.00 to $1.03. Company’s beta value stands at 3.46 points.
GSAT’s current trading volume is 641,804 while its average volume is 3.85 million shares. Last 5 day’s trade of the company showing a negative performance overall, with loosing stream of -1.94%. Globalstar, Inc. provides mobile voice and data communications services through satellite worldwide.
Will GSAT Get Buyers Even After The Recent Rally? Find Out Here
Biozone Pharmaceuticals Inc (OTCBB:BZNE) is trading with a plunge of -12.66% along with the trading price of $0.690 up till now while its today’s opening price was $0.81.
BZNE recently gained a volume of 616,342 shares while its average volume is 169,897 shares. 52 week price range of the company is $0.16 - $3.75 while today till 10:38AM its minimum price was $0.65.
Company’s 6 month’s performance gave a declining overview as it lost -34.29% while in its last 5 days its performance remained green with an upsurge of +4.53%. Biozone Pharmaceuticals, Inc., through its subsidiaries, engages in developing and manufacturing over the counter (OTC) drug products, and cosmetic and beauty products on behalf of third parties in the United States and internationally.
Has BZNE Found The Bottom and Ready To Move Up? Find Out Here
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) stock hit highest price at $0.82, after starting its trade at $0.79. Company reported an increase of +5.19% at the price of $0.810 recently; its current day range is from $0.77 to $0.82.
PVCT’s total market capitalization remained $104.19 million along with the total outstanding shares of 128.62 million. Its current volume is 526,045 in early hours of trading while if we look at its average volume than that is 550,726 shares. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications.
For How Long PVCT’s Gloss will Attract Investors? Find out via this report
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)